concept

AUTOPHAGY_PATHWAY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AUTOPHAGY_PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

46Connections

1Hypotheses

14Analyses

17Outgoing

29Incoming

0Experiments

16Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	AUTOPHAGY_PATHWAY
Key Genes/Proteins	ATG5, M2_PROTEIN, MAVS, P62_SQSTM1
Related Diseases	ACUTE_KIDNEY_INJURY, APOPTOSIS, BRAIN_INFARCT, LYSOSOMAL_DYSFUNCTION, NEUROLOGICAL_DEFICITS
Related Pathways	AKT_MTOR, AUTOPHAGY_LYSOSOME, CGAS_STING, PI3K_AKT_MTOR

Pathway Diagram

graph TD
    AUTOPHAGY_PATHWAY["AUTOPHAGY_PATHWAY"]
    AUTOPHAGY_PATHWAY -->|"inhibits"| STING["STING"]
    AUTOPHAGY_PATHWAY -->|"regulates"| PEDV_N_protein["PEDV_N_protein"]
    AUTOPHAGY_PATHWAY -->|"inhibits"| CGAS_STING["CGAS_STING"]
    AUTOPHAGY_PATHWAY -->|"inhibits"| APOPTOSIS["APOPTOSIS"]
    AUTOPHAGY_PATHWAY -->|"regulates"| p62["p62"]
    AUTOPHAGY_PATHWAY -->|"regulates"| LC3["LC3"]
    AUTOPHAGY_PATHWAY -->|"contributes to"| ACUTE_KIDNEY_INJURY["ACUTE_KIDNEY_INJURY"]
    AUTOPHAGY_PATHWAY -->|"regulates"| MAVS["MAVS"]
    AKT_MTOR["AKT_MTOR"] -->|"regulates"| AUTOPHAGY_PATHWAY
    P62_SQSTM1["P62_SQSTM1"] -->|"regulates"| AUTOPHAGY_PATHWAY
    PI3K_AKT_MTOR["PI3K_AKT_MTOR"] -->|"regulates"| AUTOPHAGY_PATHWAY
    GNETUPENDIN_A["GNETUPENDIN_A"] -->|"activates"| AUTOPHAGY_PATHWAY
    AUTOPHAGY_LYSOSOME["AUTOPHAGY_LYSOSOME"] -->|"activates"| AUTOPHAGY_PATHWAY
    mTOR["mTOR"] -->|"inhibits"| AUTOPHAGY_PATHWAY
    ATG5["ATG5"] -->|"participates in"| AUTOPHAGY_PATHWAY
    METHAMPHETAMINE["METHAMPHETAMINE"] -->|"regulates"| AUTOPHAGY_PATHWAY

Outgoing (17)

Target	Relation	Type	Str
lysosomal_function	regulates	phenotype	0.90
neurodegeneration	prevents	disease	0.80
neurodegeneration	dysfunction_causes	disease	0.80
STING	inhibits	protein	0.72
PEDV_N_protein	regulates	protein	0.72
lysosomal degradation	regulates	phenotype	0.70
tau_clearance	promotes	process	0.70
APOPTOSIS	inhibits	phenotype	0.64
p62	regulates	protein	0.64
LC3	regulates	protein	0.64
CGAS_STING	inhibits	pathway	0.64
MAVS	regulates	protein	0.56
ACUTE_KIDNEY_INJURY	contributes_to	disease	0.56
angiogenesis	activates	phenotype	0.56
NEUROLOGICAL_DEFICITS	activates	phenotype	0.56
BRAIN_INFARCT	inhibits	phenotype	0.56
inflammation	inhibits	phenotype	0.56

Incoming (29)

Source	Relation	Type	Str
TFEB	activates	protein	0.90
ULK3	activates	gene	0.90
trehalose	activates	drug	0.90
Trpml1	regulates	protein	0.90
ATG7	regulates	gene	0.90
TFEB	regulates	protein	0.90
FOXO1_protein	regulates	protein	0.80
FOXO3	activates	gene	0.80
ULK1	initiates	gene	0.80
ATG5	participates_in	protein	0.72
PI3K_AKT_MTOR	regulates	pathway	0.72
GNETUPENDIN_A	activates	drug	0.72
AKT_MTOR	regulates	pathway	0.72
P62_SQSTM1	regulates	protein	0.72
AUTOPHAGY_LYSOSOME	activates	pathway	0.72
mTOR	inhibits	protein	0.72
Mir-221-3P	inhibits	gene	0.70
lysosomal swelling	regulates	phenotype	0.70
Lysosomal Permeabilization	activates	phenotype	0.70
Hsp70	activates	protein	0.70
trehalose-independent autophagy activators	activates	drug	0.70
Rutin	activates	drug	0.70
LGALS3	modulates	protein	0.70
ADAM8	inhibits	protein	0.64
THREE_MA	inhibits	drug	0.64
METHAMPHETAMINE	regulates	drug	0.64
ATG5	regulates	protein	0.64
M2_PROTEIN	inhibits	protein	0.64
LYSOSOMAL_DYSFUNCTION	inhibits	phenotype	0.56

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Dendritic tau missorting persists through local proteostatic	0.530	neurodegeneration	Does tau dendritic missorting persist in

Mentioning Analyses (14)

Scientific analyses that reference this entity

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

neurodegeneration | 2026-04-25 | 3 hypotheses Top: 0.627

Does LRRK2's role as a lysosomal volume sensor explain the pathogenic mechanism

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.666

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.575

What validated biomarkers can determine optimal TFEB activity windows during dis

neurodegeneration | 2026-04-11 | 0 hypotheses

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

neurodegeneration | 2026-04-09 | 7 hypotheses Top: 0.455

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (16)

Multi-agent debates referencing this entity

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

closed · Rounds: 4 · Score: 0.66 · 2026-04-25

While the study establishes that trehalose-induced lysosomal permeabilization ac

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

The debate revealed conflicting evidence about whether TRPML1 activation rescues

closed · Rounds: 4 · Score: 0.72 · 2026-04-21

The debate proposed temporal TFEB modulation but identified no validated biomark

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

While the study establishes LRRK2 as a lysosomal swelling sensor and notes that

closed · Rounds: 4 · Score: 0.85 · 2026-04-16

The debate revealed conflicting evidence about whether TRPML1 activation rescues

closed · Rounds: 4 · Score: 0.46 · 2026-04-16

PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns

closed · Rounds: 4 · Score: 0.69 · 2026-04-12

PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns

closed · Rounds: 7 · Score: 0.91 · 2026-04-10

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

closed · Rounds: 4 · Score: 0.94 · 2026-04-10

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Related Research

Hypotheses and analyses mentioning AUTOPHAGY_PATHWAY in their description or question text

No additional research found

AUTOPHAGY_PATHWAY

Understanding Entity Pages

Pathway Diagram

Outgoing (17)

Incoming (29)

Targeting Hypotheses (1)

Mentioning Analyses (14)

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

Does LRRK2's role as a lysosomal volume sensor explain the pathogenic mechanism

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

What validated biomarkers can determine optimal TFEB activity windows during dis

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

What determines the specificity of calcium-dependent PPP3/calcineurin activation

Does TFEB dysfunction cause neurodegeneration or represent a compensatory respon

GBA-Synuclein Loop Therapeutics for PD

Epigenetic clocks and biological aging in neurodegeneration

Digital biomarkers and AI-driven early detection of neurodegeneration

Autophagy-lysosome pathway convergence across neurodegenerative diseases

4R-tau strain-specific spreading patterns in PSP vs CBD

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

Experiments (0)

Related Papers (0)

Debates (16)

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

While the study establishes that trehalose-induced lysosomal permeabilization ac

The debate revealed conflicting evidence about whether TRPML1 activation rescues

The debate proposed temporal TFEB modulation but identified no validated biomark

While the study establishes LRRK2 as a lysosomal swelling sensor and notes that

The debate revealed conflicting evidence about whether TRPML1 activation rescues

PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns

PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

Related Research